Sertraline HCl Market, by Type (25 mg, 50 mg, 100 mg and Others), by Application (Obsessive-Compulsive Disorder, Depression, Panic Disorder, Premenstrual Dysphoric Disorder, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	156 Pages	Coherent Market Insights	November, 2022	CMI17549930

Best Price Guarantee
Price	from $4,500
Length	156 Pages
Publisher	Coherent Market Insights
Published Date	November, 2022
SKU	CMI17549930

Sertraline HCl Market, by Type (25 mg, 50 mg, 100 mg and Others), by Application (Obsessive-Compulsive Disorder, Depression, Panic Disorder, Premenstrual Dysphoric Disorder, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Sertraline HCl belongs to a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). Sertraline HCl has the same mechanism of action as other SSRIs. It works by increasing the amount of serotonin that is available in the brain. Serotonin is a neurotransmitter, or chemical messenger, that is involved in regulating many elements of a person’s daily life, including mood, sleep, rewards, learning, and memory. Research has linked depression with low levels of serotonin. Sertraline increases the amount of serotonin present in the brain, helping to reduce chemical imbalances and improve a person’s overall mood. Sertraline is available as either an oral tablet or a liquid. Typically, a person takes a dose in the morning or evening, once a day. People using it to treat premenstrual dysphoric disorder may take it every day or only on select days of the month.

Market Dynamics

Key trends in the market include increasing prescription rate and expenditure for antidepressant drug which is expected to drive the market growth during the forecast period. For instance, according to an article published in Springer Nature Switzerland AG in March 2021, stated that the total number of Ads (antidepressants) prescriptions dispensed during COVID-19 pandemic (January to December 2020) were 78 million, 4 million more than in 2019 that costed the National Health Service (NHS) is the publicly funded healthcare system in England, £139 million (US $170.7 million) more than in 2019. Sertraline, an SSRI antidepressant drug, alone accounted for an extra £113 million (US $ 138.7 million) during 2020 than in 2019.

Key features of the study:

This report provides an in-depth analysis of the global sertraline HCl market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global sertraline HCl market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
Key companies covered as a part of this study include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Accord Biopharma, Apotex Inc., Aurobindo Pharma USA, InvaGen, Lupin, Camber Pharmaceuticals, Mylan (a part of Viatris Inc.), Sun Pharmaceutical, Wockhardt, Alpic Biotech
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global sertraline HCl market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sertraline HCl market.

Detailed Segmentation:

Global Sertraline HCl Market, By Type:
25 mg
50 mg
100 mg
Others
Global Sertraline HCl Market, By Application:
Obsessive-Compulsive Disorder
Depression
Panic Disorder
Premenstrual Dysphoric Disorder
Others
Global Sertraline HCl Market, By Distribution Channel :
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Sertraline HCl Market, By Region:
North America

By Country

U.S.
Canada
Latin America

By Country

Brazil
Mexico
Argentina
Rest of Latin America
Europe

By Country

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific

By Country

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East

By Country

GCC
Israel
Rest of Middle East
Africa

By Country

South Africa
Central Africa
North Africa
Company Profiles
Pfizer Inc *

Company Highlights

Products Portfolio

Key Highlights

Financial Performance

Strategies

Teva Pharmaceutical Industries Ltd.,
Novartis AG
Accord Biopharma
Apotex Inc.,
Aurobindo Pharma USA
InvaGen
Lupin
Camber Pharmaceuticals
Mylan N.V. (a part of Viatris Inc.)
Sun Pharmaceutical
Wockhardt
Alpic Biotech

“*” marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Type; Market Snapshot, By Application; Market Snapshot, By Distribution channel; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Opportunity; Impact Analysis; Regulatory Scenario; Market Trends; Key Developments; Epidemiology; PEST Analysis; Collaboration and Acquisition; Porters Analysis; Pipeline Analysis
4. Global Sertraline HCl Market– Impact of Coronavirus (COVID-19) Pandemic: Economic Impact; Impact on Demand and Supply; COVID-19 Impact Assessments
5. Global Sertraline HCl Market, By Type, 2017-2030, (US$ Mn): Introduction; Market Share Analysis, 2022 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends
25 mg: Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
50 mg: Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn); 100 mg; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
6. Global Sertraline HCl Market, By Application, 2017-2030, (US$ Mn): Introduction; Market Share Analysis, 2022 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Obsessive-Compulsive Disorder; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million); Depression; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million); Panic Disorder; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million); Premenstrual Dysphoric Disorder; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
7. Global Sertraline HCl Market, By Distribution channel, 2017-2030, (US$ Mn): Introduction; Market Share Analysis, 2022 and 2030 (%); Y-o-Y Growth Analysis, 2017 – 2030; Segment Trends; Hospital Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million); Retail Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million); Online Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
8. Global Sertraline HCl Market, By Region, 2017-2030, (US$ Mn): Introduction; Market Share Analysis, By Region, 2022 and 2030 (%); Y-o-Y Growth Analysis, For Regions, 2017–2030; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn); U.K.; Germany; France; Italy; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn); China; India; Japan; Australia; South Korea; ASEAN; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017-2030,(US$ Mn); North Africa; Central Africa; South Africa
9. Competitive Landscape: Heat Map Analysis; Market Share Analysis; Pfizer*; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Teva Pharmaceutical Industries Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Novartis AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Accord Biopharma; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Apotex Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Aurobindo Pharma USA; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; InvaGen; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Lupin; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Camber Pharmaceuticals; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Mylan N.V. (a part of Viatris Inc.); Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Sun Pharmaceutical; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Wockhardt; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Alpic Biotech; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; 10. Section; Research Methodology; About us; *Browse 27 market data tables and 31 figures on "Global Sertraline HCl Market” - Forecast to 2030